Regenerative Medical Solutions is a developer of regenerative medical products used to treat diabetes. The company offers ProgenMix, a media formulation that generates pancreatic progenitor cells and endocrine cell types; works with multiple human ESC and iPSC lines; and operates as a platform for drug testing and assay development. It also provides consulting services and engages in developing treatments and applications for diabetes patients. The company’s ProgenMix is used in various applications ranging from scientific research to testing the potential toxicity of candidate drugs.